Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-06 Sale |
2023-04-10 6:20 pm |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner |
60,000 | $17.32 | $1,039,200 | 8,840,750 (Indirect Direct) |
View |
| 2023-01-04 Sale |
2023-01-06 8:00 pm |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner |
60,000 | $22.01 | $1,320,876 | 9,280,639 (Indirect Direct) |
View |
| 2022-11-10 Sale |
2022-11-14 8:00 pm |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner |
60,000 | $15 | $900,000 | 9,407,300 (Indirect Direct) |
View |
| 2021-06-25 Sale |
2021-06-29 5:23 pm |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director |
473,250 | $30.83 | $14,589,493 | 8,546,750 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-04-06 Exercise |
2023-04-10 6:20 pm |
N/A 2027-08-23 |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner |
60,000 | $0 | 8,840,750 (Direct) |
View |
| 2023-04-06 Exercise |
2023-04-10 6:20 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner |
60,000 | $0.41 | 8,840,750 (Direct) |
View |
| 2022-11-15 Ownership |
2023-02-14 4:44 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director |
436,646 | $0 | 8,546,750 (Indirect) |
View |
| 2023-01-04 Exercise |
2023-01-06 8:00 pm |
N/A 2027-08-23 |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner |
60,000 | $0 | 9,280,639 (Direct) |
View |
| 2023-01-04 Exercise |
2023-01-06 8:00 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner |
60,000 | $0.41 | 9,280,639 (Direct) |
View |
| 2022-11-10 Exercise |
2022-11-14 8:00 pm |
N/A 2027-08-23 |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner |
60,000 | $0 | 9,407,300 (Direct) |
View |
| 2022-11-10 Exercise |
2022-11-14 8:00 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner |
60,000 | $0.41 | 9,407,300 (Direct) |
View |
| 2021-04-06 Ownership |
2022-02-14 5:37 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director |
233,227 | $0 | 8,546,750 (Indirect) |
View |
Ownership |
2021-02-16 5:28 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director |
0 | $0 | 9,021,000 (Indirect) |
View |
| 2020-07-24 Ownership |
2021-02-16 5:28 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director |
265,150 | $0 | 9,021,000 (Direct) |
View |
| 2020-07-24 Other |
2021-02-16 5:26 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director |
240,000 | $60.76 | 9,340,000 (Indirect) |
View |
| 2019-04-01 Gift |
2021-02-16 5:26 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director |
1,000 | $0 | 9,340,000 (Direct) |
View |